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www.supportiveandpalliativecaSofia C. Zambrano, Monica C. Fliedner, and Steffen Eychmu¨llerPurpose of review
The aim of this review is to critically appraise the existing evidence on ‘early palliative care’ (EPC), discuss
its relationship with advance care planning, and to reflect on the impact of EPC on the quality of care
provided during the last days of life.
Recent findings
There are indicators that EPC may help to avoid aggressive treatment, shorten hospital stay, improve
overall quality of life, and to see more frequently dying and death at the preferred place of care.
Summary
The evidence from randomized controlled trials supports the integration of palliative care early in the
disease trajectory. However, in terms of outcomes and quality indicators for care in the last days of life,
evidence is still lacking. Predominantly, when it comes to the outcomes which may be more difficult to
assess, such as spiritual aspects, or the social network, for which more comprehensive information is
needed. These outcomes should not be neglected in palliative care studies, particularly when they can
provide meaningful information about patient and family adjustment, and focus on psychosocial aspects
rather than physical symptom control.
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Despite a relatively rapid expansion, the provision
and implementation of palliative care into clinical
care has been hindered by cultural barriers, medical
reasoning with an emphasis on ‘cure’, and societal
attitudes towards death and dying. In particular,
there exists a general misconception that palliative
care is reserved for the last days or weeks of life, a
view which is at odds with the emphasis on early
integration advocated by the WHO since 1990 [1].
The aim of this review is to critically appraise the
existing evidence on ‘early palliative care’ (EPC),
discuss its relationship with advance care planning
(ACP), and to reflect on the impact of EPC on the
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There is no accepted definition of EPC applicable to
all contexts and clinical situations. EPC or ‘early
integration of palliative care’, in the context of
cancer care, is often defined as the ‘introduction© 2016 Wolters Kluwer 
re.comof specialized palliative care early in the disease
trajectory’ [2,3]. However, the notion of providing
early specialist palliative care has been challenged
by emphasizing the shortage of palliative care
specialists, and the need for EPC to be delivered
by oncologists [4
&
], geriatricians [5], and general
practitioners [5], among many other medical
specialists.
Difficulties in understanding and defining EPC
are further encountered when determining what
‘early’ refers to. In a systematic review of peer-
reviewed articles about early integration of palliative
care in oncology, only 18 out of 101 articlesHealth, Inc. All rights reserved.
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KEY POINTS
 The observed effects of EPC cannot be extrapolated
directly to benefits during the last days of life.
 The similarities and differences between EPC and ACP
need to be further explored.
 EPC should be ‘concurrent’ in certain disease
pathways, but its initiation should be considered
according to the individual needs of the patient.
The impact of early palliative care on the last days of life Zambrano et al.provided a time frame for the delivery of EPC [6
&&
].
Some studies, including the most recent American
Society of Clinical Oncology (ASCO) recommen-
dations, suggest the introduction of EPC at diagno-
sis of a life-limiting illness [7–9]. Others are more
specific and suggest its initiation at diagnosis of
advanced illness, or focus on life expectancy, the
patient’s performance status, or symptom burden
[6
&&
,10]. The studies suggesting life expectancy
propose a wide range of times: from 24 to 12months
or from 6 to 3 months before assumed death
[11
&
,12,13]. Other authors establish 3months before
expected death as the minimum time frame for
palliative care to be considered ‘early’ [14].
Identifying the appropriatemoment inwhich to
address palliative care needs remains a challenge.
Not only are illness trajectories often unpredictable,
but as mentioned above, most studies implement
‘early’ at very different moments [15]. An agreement
seems to be that palliative care should be integrated
before patients experience burdening symptoms for
the first time. Therefore, given the prevalence of
symptoms and the lack of significant differences in
many studies, Gaertner et al. [10] question whether
what is considered ‘early’ could already be too late, if
patients are being referred to palliative care when
their symptoms are uncontrolled. Bruera et al.
describe EPC as an ‘integrated care model’ in which
the oncologist focuses on disease management,
while palliative care teams focus on ACP as well as
on physical, spiritual, and psychosocial concerns
[10,16,17].Provided by whom?
The majority of the studies which have imple-
mented EPC approaches have done so through
specialist palliative care services. Considering that
specialist palliative care services are scarce, general
palliative care approaches are needed to incorporate
palliative care into the care of the majority of
patients with life-limiting illnesses [18
&&
]. Therefore,
there is an emphasis on teaching general skills
during medical and nursing school and during Copyright © 2016 Wolters Kluwe
1751-4258 Copyright  2016 Wolters Kluwer Health, Inc. All rights resepostgraduate training in the disciplines in which
this type of care is needed the most, such as oncol-
ogy, geriatrics, and general practice, cardiology, and
nephrology [18
&&
]. This is particularly relevant
because trained specialists can implement an inte-
grated model of palliative care in which they pro-
vide basic palliative care on their own but are able to
ascertain when they require the support and inter-
vention of specialist palliative care teams [5]. With-
out this training and experience, it is possible that
current practices of late palliative care referrals con-
tinue to occur.Differences and similarities between early
palliative care and advance care planning
The primary purpose of ACP is to ensure that the
care provided to patients meets their preferences by
respecting their decisions and autonomy [19
&
].
Although ACP can be regarded as a long-lasting
process and involves more comprehensive interven-
tions than just defining advance directives, EPC
seems to have a wider approach focused on mini-
mizing or dealing with the illness and the effects of
its treatment. Yoong et al. [20] proposed seven key
elements of EPC in cancer care: rapport building,
symptom management, addressing coping strat-
egies, establishing illness understanding, discussing
treatments, end-of-life planning, and engaging fam-
ily members. These key aspects cannot easily be
differentiated from those of complex ACP
approaches [21] and therefore, even though they
are generally described as different entities, it is still
difficult to differentiate the concepts of ACP
and EPC.What aspects and from whose perspective?
Palliative care clinicians establish a relationship first
and determine patient needs and preferences for
information before initiating the discussion of
end-of-life planning, when the health status of
the patient has changed [20]. However, there seems
to be a lack of clarity on the content and ‘effective
component’ of EPC interventions [22]. From the
patients’ perspective, the literature defines certain
topics and domains that need to be addressed in a
comprehensive early assessment and planning. For
example, symptom management, preparation for
death, achieving a sense of completion, decisions
about treatment preferences, and being treated as a
‘whole person’ are generally regarded by stakehold-
ers as goals of treatment [23]. However, goals which
are important for healthcare professionals may not
be as meaningful to patients: A study found that
patients gave more relevance than physicians tor Health, Inc. All rights reserved.
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End of life managementbeing mentally aware, having funeral arrangements
planned, not being a burden, helping others, and
coming to peace with God [23].IMPACT ON THE LAST DAYS OF LIFE
A landmark randomized controlled trial (RCT) about
the impact of EPC found that patients experienced
improved quality of life, received less aggressive
care, were more likely to establish advance direc-
tives, and lived longer [9]. Other studies identified
improvements in symptoms [3,24], depression
[24,25], distress [26], quality of life [3,24,27], and
satisfactionwith care and communication [3,28,29].
Family members reported emotional and spiritual
growth and were more satisfied with care feeling
that the needs of their relative were addressed appro-
priately [30,31]. Palliative care interventions also
influence health service utilization: Patients are less
likely to be admitted to the hospital, ICU, or emer-
gency department [29,32], and have an increased
likelihood of dying in their preferred place [29,33].
Despite highlighting that some result discrepancies
between RCTs may be related to differences in the
nature and type of interventions, the timing of
initiation or EPC, as well as defined outcomes, sev-








the observed effects cannot be extrapolated directly
to benefits during the last days of life, because the
majority of the studies do notmeasure the outcomes
which are more relevant to the last days of life,
except when measuring place of death and certain
measures of healthcare utilization.
The OPCARE 9 collaboration sought consensus
about quality indicators, including care outcomes
relevant to the last days of life [36,37]. Among the
highest ranking parameters were managing physical
symptoms such as pain, nausea/vomiting, dyspnoea,
and other aspects of care such as anxiety, and timely
communication about approaching death [36]. In the
proposed list of topicsbyRaijmakers et al. [37]were the
availability of a family room, a home visit after the
patient’s death, preferred place of death, less patients
receiving chemotherapy, limited need for pain con-
trol, fewer gastrointestinal symptoms, and adequate
communication between professionals and the
patient and families, as well as the use of care plans,
pathways or guidelines.
The evidence from RCTs supports the integ-
ration of palliative care early in the disease trajec-
tory. However, in terms of the proposed outcomes
and quality indicators for care in the last days of life,
evidence is still lacking. Predominantly, when it
comes to the outcomes which may be more difficult
to assess, such as spiritual aspects, or for whichmore Copyright © 2016 Wolters Kluwer 
312 www.supportiveandpalliativecare.comcomprehensive information is needed, such as the
social network. These outcomes should not be neg-
lected in palliative care studies, particularly when
they can provide meaningful information about
patient and family adjustment and focus on psy-




More specific aspects which can be considered as
part of better care during the last days of life can be
more easily identified in ACP studies than in EPC
studies, in which matched preferences for place of
death with actual place of death tend to be found
after most interventions, as well as less use of resus-
citation and life-sustaining equipment [21]. This
may be the case because ACP studies include these
end-of-life outcomes, whereas the majority of EPC
studies focus on more general health care and
economic outcomes.
Cost-saving studies of palliative care, in which
invasive and expensive treatments are reduced, can
provide some evidence that patients receive less
aggressive treatments at the end-of-life [40,41].
Studies on personal costs such as out of pocket costs
for family members of patients in palliative care are
still scarce [42].
Of the many studies identified, only one
assessed the effects of EPC on the treatment during
the last week of life. Zhang et al. [43] found that
patients who had discussions about the end-of-life
about 6 months before death, including discussions
about treatment preferences, were more likely to
choose more conservative treatments and to be
more realistic about their prognosis. In their study,
an end-of-life conversation was associated with a
good quality of life in the last week of life in terms of
being less likely to die in the ICU, to be resuscitated,
having less physical distress, and it was also associ-
ated with 35.7% less hospital costs during the last
week of life. They did not find differences in psycho-
logical distress or survival time. Further analyses
showed that higher medical costs were associated
withmore distress andworse overall quality of death
from the caregiver’s perspective [43,44].CLINICAL AND RESEARCH IMPLICATIONS
Reviewing the effect of ‘EPC’ on the quality of death
and dying has led us to reflect on threemain aspects:
what are the differences between EPC and ACP?,
which are the essential factors that may contribute
to a ‘good death’?, and what are the meaningful
outcomes of this relatively new approach called
‘EPC’? The answers to these questions encompass
a more profound discussion on ‘what is the effective
component of palliative care?’, and even further, on
‘what is palliative care’, ‘EPC’, and ‘ACP’?Health, Inc. All rights reserved.
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The impact of early palliative care on the last days of life Zambrano et al.In good clinical practice, early and comprehen-
sive assessment andmanagement of potential stress-
ful situations in deteriorating health conditions for
patients, family carers but also for health pro-
fessionals is warranted. In this context, timing
(‘right time for the right patient’) might be an
important issue.What are the differences between early
palliative care and advance care planning?
‘Early’ in the clinical setting is a poorly defined
term. From our perspective, ‘concurrent’ may be a
better, and less bothersome term. As Bruera and
Hui [16] pointed out palliative care or EPC is not a
matter of timing but of content. Patients may fear
‘early’ palliative care, as may do specialists and
health insurance companies (see reimbursement
policy in the United States for hospice care). In
its implementation, ‘palliative care’ has created
despair and new fears (e.g., [45
&&
,46]), and even
after decades of routine implementation in many
countries and settings, palliative care is still often
associated with dying and death [47
&&
,48]. Based on
the literature, a new ‘branding’ of what we do and
offer is important: ‘EPC’ is in other words ‘con-
current ACP’ in chronic progressive conditions
including the last months, weeks, and days of life,
and explicitly addressing fears in terms of ‘dying
and death’. By following this interpretation, EPC
would add pragmatic planning driven by the
patients’ and families’ agenda and consequently,
would structure the questions (patient-related
meaningful outcomes) that should be addressed,
offering a clear process based on a high level of
compassionate communication.Which are the essential factors that may
contribute to a ‘good death’?
Asmentioned above beyond the question of ‘when’,
the ‘what’ is crucial: evidence shows that palliative
care adds a problem-based, patient-centred, inter-
professional approach to assessment and care plan-
ning, which complements the pure medical
diagnosis-based reasoning prevailing in the medical
context.
End-of-life discussions and evaluating the goals
early enough to avoid emergency situations and
crisis decisions are specifically helpful to improve
quality of care, quality of life, and the appropriate-
ness of medical interventions (e.g., [3,43,49]). In
addition, certain barriers need to be overcome to
facilitate working hand-in-hand between specialists,
the palliative care team and/or primary care clini-
cians [50,51]. Copyright © 2016 Wolters Kluwe
1751-4258 Copyright  2016 Wolters Kluwer Health, Inc. All rights reseThere is no research directly connecting EPC
interventions and quality of death in an experimen-
tal design. There are indicators that EPCmay help to
avoid aggressive treatment, shorten hospital stay,
improve overall quality of life, and possibly to see
more frequently dying and death at the preferred
place of care. However, taking into account the
character of mixed and complex interventions with
various potentially confounding factors, and the
heterogeneity of involved populations and health
systems (which may influence endpoints such as
place of care), it is still unknown whether there is
any causality between EPC interventions and ‘a
good dying and death’.What are the meaningful outcomes of early
palliative care?
Questions regarding patient priorities as to which
outcomes of care aremore relevant in the last days of
life remain unexplored [52]. How can services best
identify and meet patients’ individual needs, and
how can they effectively measure them? Research
with a more narrow focus on the late stage of life is
required [53]. During the last days of life, the symp-
toms of dying as well as the illness itself and the
awareness of dying may affect the patient at a level
in which it had not before, and many areas of
patient and family need could be neglected, or given
less importance based on current outcome standards
[39].
There is no agreed upon core outcome set for
best care for the dying or indicators of a ‘good
death’. Much more work is needed to better under-
stand common and individual outcomes from the
perspective of patients (if possible to be captured)
and family caregivers. Partnership research projects
bringing together all stakeholders, including health
professionals, patients, and families, may provide
such information in the future.CONCLUSION
The issue of identifying an appropriate time for
‘early’ palliative care requires a reconsideration of
the characteristics of the specific setting, consider-
ing that although some patients may have a longer
life expectancy as in breast cancer or congestive
heart failure, in other diagnoses the model of EPC
delivery should include specialized palliative care
teams in addition to the basic palliative care pro-
vided by superficially trained professionals [17].
EPC and ACP are interrelated concepts which
need to be more clearly defined. We suggest that
complex ACP interventions provide comprehensive
palliative care irrespective of a disease time frame,r Health, Inc. All rights reserved.
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End of life managementwhereas EPC focuses on the clinical effects of disease
early on. The components of what makes a differ-
ence for the patients and families via EPC or ACP
need to be incorporated into routine clinical care for
patients with a life-limiting illness.
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